Betaxolol or levobetaxolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263108This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O0ZR1R6RZ2, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)- but generally known as betaxolol, which bears US NIH Compound Identifier 2369. Betaxolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Betaxolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05804MIG. The term BETAXOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules betaxolol in its Anatomical Therapeutic Chemical (ATC) Classification. BETAXOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Betaxolol or levobetaxolol bears US NLM identifiers UMLS ID C0005320 and NCI Concept Code C61652. SMILES: O(CC1CC1)CCC1CCC(OCC(O)CNC(C)C)CC1.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.